Fundraising Fox

Cambridge

Cambridge, GB · 1 known investors

Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.

BiotechDeep TechDigital HealthMedical Devices

Founders & leadership

HRHendrik Runge
Hendrik RungeFounder & CEO
UKUlrich Keyser
Ulrich KeyserScientific Founder

Board

ACAnthony Cooke
Anthony CookeChairman
JYJohn Yeomans
John YeomansBoard director
MZMax Zhu
Max ZhuBoard director

Investors · 1

Cambridge Angels groupCambridge · $195K – $1.9M

In the news

UK air defence company Cambridge Aerospace raises €259.7 million Series C at €2.94 billion valuationeu-startups.com · Aug 2026

Frequently asked questions

What does Cambridge do?
Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.
Who founded Cambridge?
Cambridge was founded by Hendrik Runge, Ulrich Keyser.
Who are Cambridge's investors?
Cambridge's investors include Cambridge Angels group.
Where is Cambridge headquartered?
Cambridge is headquartered in Cambridge, GB.